nodlik
receptor
protein
inflammasom
activ
trigger
activationinduc
matur
interleukin
il
therefor
import
develop
host
defens
variou
rna
viral
diseas
howev
implic
protein
complex
human
metapneumoviru
hmpv
diseas
fulli
studi
herein
report
inflammasom
play
detriment
role
hmpv
infect
inflammasom
inhibit
protect
mice
mortal
reduc
weight
loss
inflamm
without
impact
viral
replic
also
demonstr
inflammasom
exert
deleteri
effect
via
product
sinc
observ
reduc
mortal
weight
loss
inflamm
mice
compar
wildtyp
anim
hmpv
infect
moreov
effect
evalu
paramet
differ
wildtyp
mice
treat
inflammasom
inhibitor
product
also
abrog
bone
marrow
deriv
macrophag
defici
final
show
small
hydrophob
proteindelet
recombin
hmpv
hmpv
fail
activ
respons
cleavag
matur
furthermor
hmpv
mice
less
weight
loss
show
mortal
reduc
inflamm
compar
wildtyp
hmpvinfect
mice
thu
inflammasom
activ
seem
trigger
hmpv
sh
protein
hmpv
diseas
summari
activ
hmpv
sh
protein
inflammasom
promot
matur
exacerb
hmpvinduc
inflamm
therefor
blockad
product
use
inflammasom
inhibitor
might
novel
potenti
strategi
therapi
prevent
hmpv
infect
inflammasom
cytosol
multiprotein
complex
respons
activ
activ
proteolyt
cleav
interleukin
il
precursor
lead
releas
matur
form
among
identifi
inflammasom
nodlik
receptor
protein
inflammasom
contain
adapt
protein
apoptosisassoci
specklik
protein
asc
fulli
studi
inflammasom
activ
twostep
process
first
step
involv
prime
signal
provid
microbi
molecul
endogen
cytokin
upregul
transcript
inact
second
step
character
oligomer
subsequ
assembl
asc
complex
signal
provid
numer
stimuli
atp
poreform
toxin
viral
rna
etc
induc
potassium
efflux
calcium
signal
reactiv
oxygen
speci
gener
mitochondri
dysfunct
lysosom
ruptur
inflammasom
demonstr
activ
mani
rna
virus
could
play
distinct
role
viral
infect
inflammasom
activ
report
aggrav
newcastl
viru
murin
hepat
viru
coxsackieviru
dengu
viru
zika
viru
infect
exert
benefici
effect
host
respons
enteroviru
rabi
viru
diseas
surprisingli
although
inflammasom
could
activ
vesicular
stomat
encephalomyocard
virus
seem
influenc
pathogenesi
two
virus
case
influenza
viru
infect
sever
studi
investig
role
inflammasom
yield
controversi
result
lead
conclus
inflammasom
might
play
dual
protect
detriment
role
differ
stage
influenza
viru
infect
human
metapneumoviru
hmpv
member
metapneumoviru
genu
within
new
pneumovirida
famili
nonseg
negativestrand
envelop
rna
virus
viru
one
lead
caus
respiratori
tract
diseas
children
adult
adapt
immun
respons
gener
hmpv
usual
ineffici
protect
reinfect
repeat
throughout
life
current
licens
vaccin
prevent
hmpv
infect
treatment
still
limit
use
ribavirin
weakli
effect
antivir
agent
immunoglobulin
thu
highlight
role
inflammasom
hmpv
infect
may
provid
new
perspect
prevent
treatment
viral
diseas
date
one
studi
report
increas
product
accompani
upregul
mrna
express
hmpvinfect
children
compar
control
healthi
individu
howev
author
clarifi
role
inflammasom
hmpv
infect
current
studi
use
pharmacolog
approach
small
hydrophob
proteindelet
recombin
hmpv
hmpv
well
mice
show
inflammasom
activ
hmpv
sh
protein
activ
multiprotein
complex
exert
deleteri
effect
hmpv
infect
mice
trigger
releas
therefor
target
inflammasom
well
may
interest
develop
new
therapeut
hmpv
infect
recent
synthes
recogn
specif
inhibitor
inflammasom
sinc
preferenti
use
variou
model
diseas
recent
studi
report
impact
viabil
prolifer
highglucoseinduc
human
retin
endotheli
cell
concentr
current
studi
also
show
inhibitor
safe
usabl
human
cc
murin
cc
cell
fig
determin
inflammasom
impact
hmpv
replic
cell
treat
dose
shown
abl
block
activ
mous
bone
marrow
deriv
macrophag
human
monocyt
deriv
macrophag
human
peripher
blood
mononuclear
cell
infect
hmpv
viral
load
evalu
day
postinfect
differ
control
dmsotreat
group
fig
also
observ
viral
titer
rel
low
expect
sinc
trypsin
ad
cell
cultur
assay
thu
inflammasom
influenc
hmpv
replic
vitro
investig
inflammasom
respons
product
cell
treat
infect
hmpv
found
inflammasom
inhibit
suppress
secret
cell
significantli
decreas
concentr
cell
fig
also
confirm
respons
matur
evidenc
differ
level
control
group
hmpv
infect
fig
note
observ
product
cell
upon
hmpv
inocul
order
confirm
result
use
wildtyp
wt
bone
marrow
deriv
macrophag
bmdm
ko
bmdm
cell
line
observ
hmpvinfect
bmdm
cell
induc
product
h
bmdm
fig
convers
detect
ko
bmdm
cell
follow
hmpv
infect
notabl
detect
wt
ko
bmdm
cell
investig
inflammasom
involv
pathogenesi
hmpv
balbc
mice
treat
infect
hmpv
ld
dose
mortal
inflammasom
activ
trigger
product
hmpvinfect
cell
effect
viral
replic
cell
differenci
macrophag
use
pma
ngml
less
import
weight
loss
observ
group
compar
control
fig
nevertheless
protect
effect
treatment
slightli
decreas
treatment
delay
h
postinfect
fig
comparison
immedi
treatment
fig
thu
inflammasom
play
detriment
role
hmpv
infect
blockad
activ
may
use
prevent
also
therapi
hmpv
diseas
least
mice
investig
effect
inflammasom
hmpv
replic
determin
viral
load
lung
agreement
vitro
result
mice
inocul
hmpv
subleth
ld
dose
show
differ
lung
viral
titer
control
group
fig
therefor
like
involv
inflammasom
pathogenesi
hmpv
occur
via
direct
viral
replicationrel
pathway
inflammasom
impact
hmpv
replic
hypothes
possibl
exert
deleteri
effect
via
andor
pathway
verifi
hypothesi
measur
cytokin
level
bal
differ
time
point
balbc
mice
infect
hmpv
subleth
ld
dose
treat
level
differ
dmsotreat
mice
contrast
level
hmpvinfect
mice
significantli
decreas
upon
treatment
day
postinfect
fig
present
inflammasom
impact
hmpvinduc
secret
vitro
contrast
interferon
ifn
level
bal
significantli
decreas
upon
treatment
fig
parallel
inflammasom
inhibit
also
reduc
alter
pulmonari
capillari
permeabl
leukocyt
recruit
evidenc
signific
decreas
total
protein
level
cell
number
bal
mice
compar
control
hmpv
infect
fig
thu
inflammasom
inhibit
protect
mice
hmpv
diseas
exert
antiinflammatori
effect
moreov
antiinflammatori
effect
seem
viru
dosedepend
inflammasom
inhibit
decreas
effici
inflammatori
paramet
case
subleth
dose
ld
dose
viru
inde
treatment
induc
signific
decreas
level
day
postinfect
total
protein
level
day
postinfect
subleth
dose
postinfect
subleth
ld
dose
fig
investig
inflammasom
impact
recruit
particular
cell
type
lymphocyt
percentag
decreas
day
postinfect
upon
treatment
accompani
increas
macrophag
percentag
mice
inocul
hmpv
ld
dose
fig
lymphocyt
decreas
day
character
reduct
b
cell
fig
timedepend
differ
contribut
cell
type
hmpv
infect
detect
evidenc
predomin
polymorphonuclear
neutrophil
day
lymphocyt
day
postinfect
sinc
level
unalt
vivo
infect
determin
cytokin
exert
effect
hmpv
diseas
therefor
inhibit
hmpvinfect
balbc
mice
use
bind
protein
function
antagonist
bind
block
biolog
activ
differ
surviv
weight
loss
nontreat
mice
observ
hmpv
infect
fig
thu
involv
inflammasom
pathogenesi
hmpv
interestingli
notic
inflammasom
inhibit
alway
protect
mice
hmpv
diseas
even
viru
administ
lethal
dose
evidenc
mortal
slight
weight
loss
initi
weight
compar
dmsotreat
mice
find
enabl
us
suggest
inflammasom
essenti
pathogenesi
hmpv
balbc
mice
requir
infect
hmpv
determin
implic
inflammasom
pathogenesi
viru
could
associ
releas
therefor
mice
infect
hmpv
ld
dose
untreat
mice
show
less
weight
loss
mortal
reduc
total
protein
level
well
leukocyt
number
bal
compar
mice
without
treatment
day
postinfect
fig
paramet
includ
leukocyt
differenti
viral
replic
differ
mice
treat
mice
fig
thu
involv
inflammasom
pathogenesi
hmpv
seem
predominantli
occur
via
secret
investig
whether
hmpv
sh
protein
respons
inflammasom
activ
first
design
gener
hmpv
viru
strain
evalu
cleavag
marker
inflammasom
activ
cleavag
depend
assembl
asc
form
inflammasom
western
blot
analysi
show
hmpv
inocul
induc
cleavag
cell
fig
cleavag
howev
prevent
treatment
result
confirm
capac
hmpv
induc
inflammasom
parallel
found
hmpv
could
induc
cleavag
cell
fig
thu
sh
protein
seem
viral
compon
trigger
inflammasom
activ
experi
need
determin
mutant
viru
simpli
becom
inaccess
proinflammatori
danger
sensor
via
compartment
physic
unabl
prime
activ
inflammasom
cleav
detect
cell
lysat
supernat
h
present
cell
supernat
h
postinfect
indic
rapidli
cleav
releas
supernat
upon
hmpv
inocul
also
investig
absenc
sh
protein
could
attenu
infect
hmpv
differ
viral
replic
hmpv
hmpv
observ
cell
fig
product
abrog
hmpv
cell
fig
tendenc
observ
vivo
studi
inde
imag
mice
mortal
seen
hmpv
mice
wherea
slight
weight
loss
well
reduc
total
protein
level
leukocyt
number
bal
lung
histopatholog
score
observ
compar
hmpvinfect
mice
day
postinfect
fig
fig
differ
level
well
leukocyt
differenti
observ
day
hmpv
hmpvinfect
mice
fig
howev
signific
decreas
seen
day
hmpv
group
fig
thu
inflammasom
inhibit
sh
protein
delet
attenu
inflamm
lung
injuri
moreov
sh
protein
impact
viral
balbc
mice
inocul
hmpv
subleth
x
ld
dose
x
pfu
per
mous
presenc
absenc
mgkg
treatment
repeat
next
two
day
timeday
cytokin
level
measur
bal
valu
shown
mean
sem
mannwhitney
utest
p
p
vs
dmso
n
per
group
group
compar
dmso
replic
demonstr
differ
viral
load
lung
hmpv
hmpvinfect
group
fig
altogeth
conclud
case
hmpv
infect
inflammasom
activ
trigger
viral
sh
protein
studi
clearli
show
role
inflammasom
particular
pathogenesi
hmpv
use
pharmacolog
approach
bmdm
ko
cell
mice
crucial
compon
innat
immun
system
inflammasom
serv
import
role
host
defens
recogn
rna
viral
pathogen
trigger
immun
respons
although
inflammasom
report
implic
mani
rna
viral
diseas
distinct
function
littl
known
involv
protein
complex
pathogenesi
hmpv
context
present
studi
show
first
time
inflammasom
play
detriment
role
hmpv
infect
effect
mediat
viral
sh
protein
contribut
inflammasom
pathogenesi
rna
virus
occur
role
trigger
inflamm
inflamm
viral
replic
herein
demonstr
involv
inflammasom
pathogenesi
hmpv
proce
via
proinflammatori
effect
inde
vitro
vivo
studi
show
viral
replic
almost
unalt
wherea
inflamm
attenu
upon
inflammasom
inhibit
hmpv
infect
find
consist
two
studi
also
shown
inflammasom
impact
viral
replic
influenza
chikungunya
diseas
nevertheless
suppress
inflammasom
demonstr
decreas
fulmin
hepat
zika
viru
replic
increas
newcastl
viru
replic
word
inflammasom
play
distinct
role
replic
rna
virus
per
group
ce
total
protein
leukocyt
recruit
evalu
bal
mice
valu
shown
mean
sem
anova
follow
tukey
post
hoc
p
p
vs
n
per
group
http
inflammasom
activ
promot
matur
cytokin
studi
inflammasomeindepend
secret
observ
hmpvinfect
cell
cell
find
consolid
recent
vitro
studi
investig
rsv
closest
viru
relat
hmpv
also
belong
pneumovirida
famili
author
report
secret
trigger
rsvinduc
activ
primari
human
lung
epitheli
cell
although
inflammasom
respons
secret
infect
cell
inhibit
protein
complex
decreas
level
also
hmpvinfect
mice
furthermor
three
inflammatori
paramet
includ
alter
pulmonari
capillari
permeabl
leukocyt
recruit
lung
histopatholog
score
also
decreas
upon
inflammasom
inhibit
data
uniqu
consist
sever
previou
report
thu
inflammasom
may
impact
secret
also
exert
proinflammatori
effect
via
unknown
pathway
rna
viral
diseas
gener
hmpv
infect
particular
explain
proinflammatori
function
inflammasom
suggest
activ
may
occur
concert
proinflammatori
pathway
lipotox
oxid
stressand
pathway
suggest
inflammasom
exert
proinflammatori
effect
hmpv
infect
biolog
activ
inde
cytokin
identifi
import
regul
inflamm
evidenc
capac
stimul
neutrophil
macrophag
recruit
infiltr
condit
induc
lung
vascular
permeabl
damag
also
identifi
activ
product
importantli
report
inflammasom
inhibit
balbc
mice
delet
gene
encod
mice
induc
less
weight
loss
decreas
mortal
inflamm
hmpvinfect
mice
moreov
protect
effect
hmpv
diseas
differ
inflammasom
inhibit
delet
mice
briefli
inflammasomeinduc
releas
play
crucial
role
hmpv
infect
least
mice
case
balbc
mice
mortal
found
anim
infect
hmpv
ld
dose
treat
fig
contrast
mortal
detect
infect
mice
given
treatment
fig
furthermor
inflammasom
inhibit
found
decreas
level
bal
balbc
mice
fig
level
case
mice
day
postinfect
fig
parallel
level
bal
balbc
mice
strongli
higher
mice
fig
fig
find
indic
hmpvinduc
inflamm
sever
balbc
mice
role
role
inflammasom
hmpv
diseas
inflammasom
import
former
mice
hmpv
infect
differ
suscept
two
murin
strain
hmpv
possibl
explan
although
inflammasom
activ
trigger
matur
show
involv
pathogenesi
hmpv
moreov
involv
occur
earli
stage
infect
process
level
decreas
upon
inhibitor
treatment
day
postinfect
find
surpris
sinc
well
famili
cytokin
wide
consid
earlyrespons
cytokin
releas
earliest
stage
immun
respons
contrast
secret
unalt
infect
influenc
pathogen
hmpv
mice
might
explain
limit
presenc
macrophag
hmpv
infect
shown
abund
sourc
vitro
studi
fig
contrast
polymorphonuclear
neutrophil
abund
day
lymphocyt
domin
day
postinfect
fig
inflammasom
activ
gener
employ
twostep
mechan
gener
first
signal
permit
gener
trigger
recognit
viral
pathogen
tolllik
receptor
tlr
retino
acidinduc
geneilik
receptor
herein
investig
mechan
first
signal
occur
howev
think
receptor
may
respons
process
recent
studi
demonstr
among
variou
tlr
includ
provid
first
signal
inflammasom
activ
rsvinfect
lung
epitheli
cell
furthermor
mice
induc
less
weight
loss
decreas
inflamm
differ
viral
replic
compar
wildtyp
mice
hmpv
infect
find
consist
result
use
either
mice
pharmacolog
approach
block
inflammasom
activ
recent
shown
rna
virus
trigger
inflammasom
activ
receptor
interact
protein
rip
protein
signal
pathway
briefli
rna
viru
infect
initi
assembl
complex
promot
activ
dynaminrel
protein
transloc
mitochondria
result
mitochondria
damag
excess
reactiv
oxygen
speci
gener
subsequ
inflammasom
activ
rna
viral
compon
respons
trigger
pathway
identifi
sever
viral
infect
influenza
viru
protein
measl
viru
v
protein
rsv
sh
protein
encephalomyocard
viru
rhinoviru
protein
coronaviru
e
protein
enteroviru
protein
among
protein
encephalomyocard
viru
rhinoviru
protein
well
rsv
sh
protein
recogn
viroporin
viroporin
rna
virus
report
respons
mitochondri
alter
furthermor
insert
host
cell
membran
viroporin
enabl
viru
tune
ion
permeabl
stimul
varieti
viral
cycl
stage
taken
togeth
hypothes
hmpv
sh
protein
may
activ
inflammasom
hmpv
diseas
suggest
act
viroporin
genom
structur
hmpv
close
relat
rsv
hmpv
virus
previous
report
gener
group
group
b
strain
gener
hmpv
use
strain
group
verifi
hypothesi
addit
blockad
cleavag
reliabl
marker
inflammasom
activ
result
lack
sh
protein
treatment
found
ident
treatment
sh
delet
effect
viral
replic
vitro
vivo
find
consolid
previou
studi
use
hmpv
virus
also
detect
hmpv
mice
protect
sever
infect
evidenc
mortal
less
weight
loss
reduc
inflamm
evolut
hmpv
infect
differ
hmpv
wildtyp
hmpvinfect
mice
receiv
treatment
acknowledg
measur
taken
detect
defect
interf
particl
viral
prepar
parallel
inflammasom
inhibit
influenc
pathogenesi
hmpv
taken
togeth
conclud
hmpv
sh
protein
might
activ
inflammasom
addit
identifi
role
modul
type
ifn
signal
pathway
deterior
cell
host
membran
permeabl
regul
viral
fusogen
function
reduc
cell
activ
summari
report
first
time
detriment
role
inflammasom
hmpv
infect
murin
model
mechanist
hmpv
sh
protein
trigger
inflammasom
activ
lead
cleavag
form
matur
although
cytokin
crucial
control
viral
replic
play
major
role
inflammatori
process
identifi
import
featur
pathogen
hmpv
thu
involv
inflammasom
hmpv
diseas
occur
via
inflammatori
process
rather
viru
replic
context
believ
antiinflammatori
treatment
gener
drug
particular
ie
use
inhibitor
may
consid
novel
potenti
strategi
prevent
treatment
hmpv
diseas
sixweek
old
femal
balbc
mice
bodi
weight
g
purchas
charl
river
laboratori
sennevil
qc
canada
mice
kindli
provid
dr
steve
lacroix
infecti
diseas
research
centr
quebec
citi
qc
canada
agematch
wildtyp
mice
purchas
charl
river
laboratori
mice
hous
pathogenfre
condit
anim
research
facil
quebec
univers
health
centr
quebec
citi
qc
canada
allow
acclimat
one
week
prior
start
experi
experiment
procedur
mice
approv
anim
protect
committe
quebec
univers
health
centr
accord
guidelin
canadian
council
anim
care
protocol
number
cpac
inocul
substanc
euthanasia
mice
anaesthet
inhal
isofluran
vapor
concentr
oxygen
flow
rate
adjust
lmin
individu
bodi
weight
clinic
sign
use
monitor
anim
health
respons
infect
record
daili
mice
euthan
co
inhal
upon
loss
initi
bodi
weight
cell
atcc
manassa
va
usa
maintain
minim
essenti
medium
thermo
fisher
scientif
burlington
canada
supplement
fetal
bovin
serum
fb
wisent
saintjeanbaptist
qc
canada
hepe
buffer
gl
murin
macrophag
cell
kindli
provid
dr
sachiko
sato
infecti
diseas
research
centr
quebec
citi
qc
canada
maintain
dulbecco
modifi
eagl
medium
thermo
fisher
scientif
supplement
fb
penicillinstreptomycin
thermo
fisher
scientif
human
monocytelik
cell
gener
provid
dr
francesca
cicchetti
quebec
univers
health
centr
quebec
citi
qc
canada
maintain
rpmi
medium
thermo
fisher
scientif
supplement
fb
penicillinstreptomycin
nonessenti
amino
acid
thermo
fisher
scientif
mm
sigma
aldrich
oakvil
canada
differenti
cell
macrophag
addit
phorbol
ngml
sigma
aldrich
carri
vitro
experi
immort
murin
bonemarrow
deriv
macrophag
wt
bmdm
iwt
bmdm
kindli
provid
dr
py
centr
intern
de
recherch
en
infectiologi
ciri
lyon
franc
maintain
dulbecco
modifi
eagl
medium
thermo
fisher
scientif
high
glucos
supplement
fb
penicillinstreptomycin
thermo
fisher
scientif
hmpv
strain
clinic
isol
recombin
hmpv
strain
grown
cell
concentr
previous
describ
virus
concentr
ultracentrifug
pellet
resuspend
pb
viral
stock
sequenc
titer
determin
immunostain
express
plaqueform
unit
pfu
per
millilit
strategi
construct
plasmid
encod
fulllength
genom
cdna
hmpv
strain
genbank
access
number
subsequ
product
recombin
virus
describ
detail
briefli
fulllength
genom
cdna
hmpv
strain
gener
rtpcr
use
superscript
ii
revers
transcriptas
thermo
fisher
scientif
amplifi
phusion
dna
polymeras
new
england
biolab
whitbi
canada
gibson
assembl
clone
kit
new
england
biolab
perform
integr
genom
viral
cdna
plasmid
promega
madison
wi
usa
contain
termin
hepat
delta
viru
hdv
ribozym
promot
gener
hmpv
viru
mention
plasmid
amplifi
use
specif
primer
design
match
sh
gene
start
sequenc
intergen
shg
region
order
extract
complet
sh
gene
sequenc
amplif
linear
dna
phosphoryl
ligat
ligas
recircular
shorten
hmpv
genom
newli
gener
hmpv
genom
plasmid
valid
complet
sequenc
prior
transfect
cell
cotransfect
lipofectamin
thermo
fisher
scientif
hmpv
genom
plasmid
support
plasmid
express
n
p
l
viral
orf
seven
hour
transfect
medium
replac
optimem
supplement
nonessenti
amino
acid
thermo
fisher
scientif
transfect
cell
incub
four
day
point
cell
ad
transfect
bsr
cell
cocultur
addit
fresh
trypsin
two
day
two
three
day
cocultur
cell
harvest
sonic
centrifug
x
g
min
room
temperatur
supernat
collect
dilut
infect
medium
optimem
supplement
trypsin
inocul
onto
confluent
monolay
infect
monolay
monitor
appear
characterist
cytopath
effect
harvest
viru
amplifi
serial
passag
cell
cc
concentr
inhibitor
tocri
bioscienc
bristol
uk
determin
cell
use
celltit
aqueou
one
solut
cell
prolifer
assay
promega
accord
manufactur
instruct
cell
treat
incub
h
equival
dilut
dimethyl
sulfoxid
dmso
sigma
aldrich
serv
control
cell
inocul
wildtyp
hmpv
hmpv
moi
per
well
incub
cell
lysat
supernat
harvest
h
postinfect
elisa
western
blot
analys
addit
viral
titer
determin
immunostain
three
day
postinfect
express
pfu
per
millilit
bmdm
iwt
cell
plate
wash
pb
inocul
optimem
mock
wildtyp
hmpv
hmpv
moi
optimem
trypsin
h
adsorpt
inocula
remov
chang
fresh
cell
cultur
medium
dmem
high
glucos
fb
penicillinstreptomycin
thermo
fisher
scientif
cell
supernat
harvest
h
postinfect
perform
quantif
elisa
assay
duoset
elisa
r
system
accord
manufactur
instruct
viral
titrat
previous
describ
preliminari
studi
carri
determin
subleth
ld
lethal
dose
viru
mice
balbc
mice
inocul
intranas
hmpv
strain
subleth
dose
x
ld
x
lethal
dose
pfu
per
mous
hmpv
wherea
wildtyp
mice
inocul
x
pfu
hmpv
strain
ld
dose
mice
fourfold
higher
balbc
mice
mice
less
suscept
hmpv
infect
compar
balbc
mice
equal
volum
optimem
medium
serv
mock
infect
block
inflammasom
activ
mgkg
mix
administ
intranas
time
viru
howev
also
given
h
postinfect
singl
experi
equival
dilut
dmso
sigma
aldrich
serv
control
treatment
repeat
day
two
consecut
day
inhibit
immedi
follow
inocul
viru
mice
underw
intraperiton
inject
dose
r
system
minneapoli
mn
usa
treatment
repeat
day
two
consecut
day
infect
control
mice
given
steril
salin
similar
manner
evalu
viral
titer
day
postinfect
mice
euthan
whole
lung
harvest
homogen
pb
mlsampl
use
th
tissu
homogen
omni
intern
kennesaw
ga
usa
supernat
collect
centrifug
x
g
minut
methylcellulos
use
determin
viral
titer
immunostain
express
pfu
per
gram
lung
day
postinfect
mice
euthan
bronchoalveolar
lavag
bal
perform
steril
cold
phosphatebuff
salin
pb
cell
lavag
fluid
pellet
centrifug
x
g
min
suspend
pb
wherea
bal
supernat
collect
evalu
inflammatori
paramet
viabl
cell
number
determin
use
hemocytomet
express
number
per
millilit
bal
differenti
cell
count
suspend
cell
spun
onto
slide
use
shandon
cytospin
cytocentrifug
thermo
fisher
scientif
x
g
min
room
temperatur
slide
airdri
stain
maygrunewald
giemsa
solut
sigma
aldrich
accord
manufactur
instruct
differenti
cell
count
made
standard
morpholog
criteria
count
least
cell
per
sampl
result
express
differenti
percentag
concentr
cell
supernat
bal
fluid
determin
use
mous
human
duoset
elisa
r
system
mous
elisa
pair
set
sino
biolog
beij
china
accord
manufactur
instruct
result
express
picogram
per
millilit
bal
total
protein
level
bal
supernat
determin
use
quick
start
bradford
protein
assay
biorad
laboratori
mississauga
canada
accord
manufactur
instruct
result
express
milligram
per
millilit
bal
order
analyz
lunginfiltr
immun
cell
mice
deepli
anesthet
perfus
intracardi
dpb
without
prior
day
day
postinfect
whole
lung
collect
digest
liberas
tl
roch
diagnost
mannheim
germani
lung
homogen
incub
h
filter
cell
strainer
bd
bioscienc
mississaugo
canada
cell
suspens
centrifug
x
g
min
room
temperatur
supernat
aspir
cell
wash
twice
dpb
plu
fb
cell
first
incub
ice
min
fixabl
viabil
stain
bd
bioscienc
ca
usa
wash
incub
ice
min
purifi
rat
antimous
mous
fc
block
bd
bioscienc
ca
usa
red
blood
cell
lyse
bd
pharm
lyse
rbc
lysi
buffer
biolegend
san
diego
ca
usa
recov
leukocyt
wash
resuspend
dpb
wash
step
cell
incub
ice
min
pool
antibodi
siglecf
bd
bioscienc
ca
usa
number
cell
determin
precis
count
bead
biolegend
san
diego
ca
usa
label
cell
wash
resuspend
dpb
flow
cytometri
analys
data
acquisit
perform
use
bd
sorp
lsr
ii
bd
facsdiva
softwar
respect
total
protein
cell
supernat
concentr
use
amicon
centrifug
filter
millipor
canada
etobicok
canada
accord
manufactur
instruct
concentr
protein
cell
lysat
supernat
determin
use
quick
start
bradford
protein
assay
equal
protein
amount
separ
sdspage
gel
transfer
nitrocellulos
membran
ge
healthcar
life
scienc
mississauga
canada
block
use
bsa
sigma
aldrich
primari
antibodi
use
dilut
goat
r
system
rabbit
anticleav
mous
cell
signal
technolog
boston
usa
secondari
antibodi
use
dilut
hrpconjug
rabbit
antigoat
r
system
hrpconjug
rabbit
antimous
mous
antirabbit
cell
signal
technolog
signal
detect
carri
use
west
pico
plu
chemiluminesc
substrat
thermo
fisher
scientif
day
postinfect
mice
euthan
lung
remov
tissu
fix
paraformaldehyd
embed
paraffin
section
slice
stain
hematoxylin
eosin
slide
digit
magnif
use
nanozoom
slide
scanner
hamamatsu
japan
score
use
ndp
viewer
softwar
hamamatsu
japan
histopatholog
score
determin
pathologist
medic
biologist
blind
experiment
data
semiquantit
scale
use
score
bronchial
endobronchi
peribronchi
perivascular
interstiti
pleural
intraalveolar
inflamm
score
repres
consensu
two
observ
result
express
lung
total
inflammatori
score
statist
test
conduct
use
graphpad
prism
version
graphpad
softwar
la
jolla
ca
usa
result
express
mean
sem
group
n
refer
sampl
size
surviv
data
analyz
compar
kaplanmei
curv
use
logrank
test
viral
titer
cytokin
total
protein
level
immun
cell
recruit
cell
differenti
well
lung
histopatholog
score
analyz
use
unpair
student
ttest
mannwhitney
utest
oneway
analysi
varianc
anova
follow
tukey
post
hoc
kruskalw
test
follow
dunn
post
hoc
multipl
comparison
differ
consid
statist
signific
p
